Stockscreener 앱 받기
1.83
9.50%
-0.17
전일 마감가:
$2.00
열려 있는:
$1.92
하루 거래량:
118.02K
Relative Volume:
0.66
시가총액:
$47.61M
수익:
$1.79M
순이익/손실:
$-70.90M
주가수익비율:
-0.1178
EPS:
-15.54
순현금흐름:
$-34.95M
1주 성능:
-18.83%
1개월 성능:
+13.12%
6개월 성능:
-45.48%
1년 성능:
-19.20%
1일 변동 폭
$1.80
$2.0336
1주일 범위
$1.80
$2.27
52주 변동 폭
$1.26
$16.94
센티 바이오사이언시스 Stock (SNTI) Company Profile
명칭
Senti Biosciences Inc
전화
(650) 239-2030
주소
2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO
SNTI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNTI
Senti Biosciences Inc
|
1.82 | 52.32M | 1.79M | -70.90M | -34.95M | -15.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.04 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
627.25 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.36 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.00 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.91 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
센티 바이오사이언시스 Stock (SNTI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-14 | 개시 | H.C. Wainwright | Buy |
| 2025-06-06 | 개시 | Laidlaw | Buy |
| 2022-10-07 | 개시 | Morgan Stanley | Equal-Weight |
센티 바이오사이언시스 주식(SNTI)의 최신 뉴스
Combining machine learning predictions for Senti Biosciences Inc.Weekly Trade Recap & AI Powered Market Entry Ideas - newser.com
Will Senti Biosciences Inc. stock recover faster than peersJuly 2025 Drop Watch & Smart Allocation Stock Reports - newser.com
Strategies to average down on Senti Biosciences Inc.July 2025 Trends & Weekly Return Optimization Alerts - newser.com
Will a bounce in Senti Biosciences Inc. offer an exit2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - newser.com
Why Senti Biosciences Inc. stock could benefit from AI revolutionTrade Entry Summary & Real-Time Buy Zone Alerts - newser.com
Is Senti Biosciences Inc. stock resilient to inflation2025 Earnings Impact & Free Long-Term Investment Growth Plans - newser.com
Senti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, at the American Society of Hematology (ASH) Annual Meeting 2025 - The Manila Times
Will Senti Biosciences Inc. stock deliver shareholder valueGap Up & Free Technical Confirmation Trade Alerts - newser.com
Measuring Senti Biosciences Inc.’s beta against major indicesJuly 2025 Short Interest & Risk Controlled Swing Alerts - newser.com
Candlestick signals on Senti Biosciences Inc. stock todayEarnings Miss & Community Driven Trade Alerts - newser.com
Why Senti Biosciences Inc. stock appeals to analysts2025 Year in Review & Daily Stock Trend Reports - newser.com
What insider trading reveals about Senti Biosciences Inc. stock2025 Geopolitical Influence & Smart Money Movement Tracker - newser.com
Is Senti Biosciences Inc. stock attractive for ETFsWeekly Gains Summary & Growth Oriented Trading Recommendations - newser.com
Is Senti Biosciences Inc. trending in predictive chart modelsEarnings Overview Summary & Weekly Top Stock Performers List - newser.com
Is Senti Biosciences Inc. forming a reversal patternJuly 2025 Rallies & Verified Momentum Stock Ideas - newser.com
Applying Wyckoff theory to Senti Biosciences Inc. stock2025 Price Action Summary & Weekly Consistent Profit Watchlists - newser.com
How Senti Biosciences Inc. stock benefits from global expansionWeekly Stock Analysis & Low Risk Growth Stock Ideas - newser.com
Will Senti Biosciences Inc. stock keep outperforming rivals2025 Trade Ideas & Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-31 05:19:34 - newser.com
Published on: 2025-10-31 03:42:19 - newser.com
What analysts say about Senti Biosciences Inc stockStock Watchlist Updates & Free Dynamic Investment Techniques - earlytimes.in
Published on: 2025-10-29 02:48:48 - newser.com
Published on: 2025-10-29 00:36:43 - newser.com
센티 바이오사이언시스 (SNTI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
센티 바이오사이언시스 주식 (SNTI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Lu Timothy K | CEO |
Feb 06 '25 |
Sale |
4.36 |
545 |
2,376 |
82,082 |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Off. |
Feb 04 '25 |
Sale |
4.07 |
1,297 |
5,279 |
8,803 |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Off. |
Feb 06 '25 |
Sale |
4.37 |
182 |
795 |
8,621 |
1.29%
0.56%
자본화:
|
볼륨(24시간):